What Is Familial Hypercholesterolemia, and Why Does It Matter?
作者信息
Khera Amit V, Hegele Robert A
机构信息
Center for Genomic Medicine and Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston (A.V.K.).
Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA (A.V.K.).
出版信息
Circulation. 2020 Jun 2;141(22):1760-1763. doi: 10.1161/CIRCULATIONAHA.120.046961. Epub 2020 Jun 1.
Abstract
摘要
相似文献
1
What Is Familial Hypercholesterolemia, and Why Does It Matter?什么是家族性高胆固醇血症，它为何重要？
Circulation. 2020 Jun 2;141(22):1760-1763. doi: 10.1161/CIRCULATIONAHA.120.046961. Epub 2020 Jun 1.
2
Editorial Commentary: What Determines the Risk of Cardiovascular Disease in Familial Hypercholesterolemia?社论评论：什么决定了家族性高胆固醇血症中心血管疾病的风险？
Trends Cardiovasc Med. 2021 May;31(4):216-217. doi: 10.1016/j.tcm.2020.04.001. Epub 2020 May 11.
3
What Is the Prevalence of Familial Hypercholesterolemia?家族性高胆固醇血症的患病率是多少？
Arterioscler Thromb Vasc Biol. 2021 Oct;41(10):2629-2631. doi: 10.1161/ATVBAHA.121.316862. Epub 2021 Aug 26.
4
Homozygous Familial Hypercholesterolemia in Spain: Prevalence and Phenotype-Genotype Relationship.西班牙的纯合子家族性高胆固醇血症：患病率及表型-基因型关系
Circ Cardiovasc Genet. 2016 Dec;9(6):504-510. doi: 10.1161/CIRCGENETICS.116.001545. Epub 2016 Oct 26.
5
Familial hypercholesterolemia diagnostic challenge: Is Artificial Intelligence the key?家族性高胆固醇血症的诊断挑战：人工智能是关键吗？
Atherosclerosis. 2024 Apr;391:117435. doi: 10.1016/j.atherosclerosis.2023.117435. Epub 2023 Dec 27.
6
Phenotypical, Clinical, and Molecular Aspects of Adults and Children With Homozygous Familial Hypercholesterolemia in Iberoamerica.《伊比利亚美洲地区同型合子家族性高胆固醇血症成人和儿童的表型、临床和分子特征》
Arterioscler Thromb Vasc Biol. 2020 Oct;40(10):2508-2515. doi: 10.1161/ATVBAHA.120.313722. Epub 2020 Aug 6.
7
Subclinical coronary atherosclerosis and cardiovascular risk stratification in heterozygous familial hypercholesterolemia patients undergoing statin treatment.杂合子家族性高胆固醇血症患者他汀类药物治疗后的亚临床冠状动脉粥样硬化与心血管风险分层。
Curr Opin Lipidol. 2019 Apr;30(2):82-87. doi: 10.1097/MOL.0000000000000573.
8
A familial hypercholesterolemia week in Kyrgyzstan: The joint scientific and practical symposium with the European Atherosclerosis Society (EAS), the International Atherosclerosis Society (IAS) and the Kyrgyz Society of Cardiology (KSC).吉尔吉斯斯坦的家族性高胆固醇血症周：与欧洲动脉粥样硬化学会（EAS）、国际动脉粥样硬化学会（IAS）和吉尔吉斯斯坦心脏病学会（KSC）联合举办的科学与实践研讨会。
Atherosclerosis. 2019 Feb;281:198-199. doi: 10.1016/j.atherosclerosis.2018.11.036. Epub 2018 Dec 3.
9
Clinical features, diagnosis and frequency of familial hypercholesterolemia.家族性高胆固醇血症的临床特征、诊断及发病率
Beitr Infusionsther. 1988;23:26-32.
10
Familial hypercholesterolemia: genetic predisposition to atherosclerosis.家族性高胆固醇血症：动脉粥样硬化的遗传易感性。
Medsurg Nurs. 2004 Aug;13(4):253-7.
引用本文的文献
1
Assessment of Primary Health Care Physicians' Awareness, Knowledge, and Practice of Familial Hypercholesterolemia in Jazan, Saudi Arabia.沙特阿拉伯吉赞地区初级保健医生对家族性高胆固醇血症的认知、知识和实践评估
Cureus. 2025 Jul 9;17(7):e87625. doi: 10.7759/cureus.87625. eCollection 2025 Jul.
2
Beyond identification of familial hypercholesterolemia: Improving downstream visits and treatments in a large health care system: Improving FH Care.超越家族性高胆固醇血症的识别：改善大型医疗保健系统中的后续就诊和治疗：改善FH护理。
Am J Prev Cardiol. 2025 Jan 24;21:100937. doi: 10.1016/j.ajpc.2025.100937. eCollection 2025 Mar.
3
Development and implementation of a digiphysical screening model with nationwide reach to diagnose familial hypercholesterolemia.开发并实施一种具有全国范围影响力的数字物理筛查模型，用于诊断家族性高胆固醇血症。
Digit Health. 2025 Jan 23;11:20552076241311156. doi: 10.1177/20552076241311156. eCollection 2025 Jan-Dec.
4
Between hope and reality: treatment of genetic diseases through nucleic acid-based drugs.在希望与现实之间：通过核酸药物治疗遗传疾病
Commun Biol. 2024 Apr 23;7(1):489. doi: 10.1038/s42003-024-06121-9.
5
Aortic Wall Thickness as a Surrogate for Subclinical Atherosclerosis in Familial and Nonfamilial Hypercholesterolemia: Quantitative 3D Magnetic Resonance Imaging Study and Interrelations with Computed Tomography Calcium Scores, and Carotid Ultrasonography.主动脉壁厚度作为家族性和非家族性高胆固醇血症中亚临床动脉粥样硬化的替代指标：定量三维磁共振成像研究及其与计算机断层扫描钙评分和颈动脉超声检查的相互关系
J Clin Med. 2023 Aug 27;12(17):5589. doi: 10.3390/jcm12175589.
6
International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia.国际动脉粥样硬化学会家族性高胆固醇血症管理最佳实践实施指南。
Nat Rev Cardiol. 2023 Dec;20(12):845-869. doi: 10.1038/s41569-023-00892-0. Epub 2023 Jun 15.
7
The risk of various types of cardiovascular diseases in mutation positive familial hypercholesterolemia; a review.突变阳性家族性高胆固醇血症中各类心血管疾病的风险；综述
Front Genet. 2022 Dec 6;13:1072108. doi: 10.3389/fgene.2022.1072108. eCollection 2022.
8
Management of Familial Hypercholesterolemia with Special Emphasis on Evinacumab.家族性高胆固醇血症的管理，特别强调依维苏单抗。
Biomedicines. 2022 Dec 16;10(12):3273. doi: 10.3390/biomedicines10123273.
9
Prevalence of familial hypercholesterolemia in patients with confirmed premature coronary artery disease in Ranchi, Jharkhand.在贾坎德邦兰契确诊为早发性冠状动脉疾病的患者中家族性高胆固醇血症的患病率
Egypt Heart J. 2022 Dec 17;74(1):83. doi: 10.1186/s43044-022-00320-7.
10
Genetic Spectrum of Familial Hypercholesterolaemia in the Malaysian Community: Identification of Pathogenic Gene Variants Using Targeted Next-Generation Sequencing.马来西亚人群家族性高胆固醇血症的遗传谱：应用靶向下一代测序技术鉴定致病性基因突变。
Int J Mol Sci. 2022 Nov 29;23(23):14971. doi: 10.3390/ijms232314971.
本文引用的文献
1
Prevalence of Familial Hypercholesterolemia Among the General Population and Patients With Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analysis.家族性高胆固醇血症在普通人群和动脉粥样硬化性心血管疾病患者中的患病率：系统评价和荟萃分析。
Circulation. 2020 Jun 2;141(22):1742-1759. doi: 10.1161/CIRCULATIONAHA.119.044795. Epub 2020 May 29.
2
Association of Monogenic vs Polygenic Hypercholesterolemia With Risk of Atherosclerotic Cardiovascular Disease.单基因与多基因高胆固醇血症与动脉粥样硬化性心血管疾病风险的关联。
JAMA Cardiol. 2020 Apr 1;5(4):390-399. doi: 10.1001/jamacardio.2019.5954.
3
Cholesterol-Lowering Agents.降胆固醇药物。
Circ Res. 2019 Feb;124(3):364-385. doi: 10.1161/CIRCRESAHA.118.313238.
4
The complex molecular genetics of familial hypercholesterolaemia.家族性高胆固醇血症的复杂分子遗传学。
Nat Rev Cardiol. 2019 Jan;16(1):9-20. doi: 10.1038/s41569-018-0052-6.
5
Familial hypercholesterolaemia.家族性高胆固醇血症。
Nat Rev Dis Primers. 2017 Dec 7;3:17093. doi: 10.1038/nrdp.2017.93.
6
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.低密度脂蛋白导致动脉粥样硬化性心血管疾病。1. 来自遗传、流行病学和临床研究的证据。欧洲动脉粥样硬化学会共识小组的共识声明。
Eur Heart J. 2017 Aug 21;38(32):2459-2472. doi: 10.1093/eurheartj/ehx144.
7
Genetic identification of familial hypercholesterolemia within a single U.S. health care system.在美国单一医疗体系中对家族性高胆固醇血症进行基因鉴定。
Science. 2016 Dec 23;354(6319). doi: 10.1126/science.aaf7000.
8
Polygenic Versus Monogenic Causes of Hypercholesterolemia Ascertained Clinically.临床确诊的高胆固醇血症的多基因与单基因病因
Arterioscler Thromb Vasc Biol. 2016 Dec;36(12):2439-2445. doi: 10.1161/ATVBAHA.116.308027. Epub 2016 Oct 20.
9
Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia.对重度高胆固醇血症患者进行家族性高胆固醇血症基因测序的诊断率及临床应用价值
J Am Coll Cardiol. 2016 Jun 7;67(22):2578-89. doi: 10.1016/j.jacc.2016.03.520. Epub 2016 Apr 3.
10
Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217.导致家族性高胆固醇血症的突变：对哥本哈根普通人群研究中的 98098 个人进行筛查，估计患病率为 1/217。
Eur Heart J. 2016 May 1;37(17):1384-94. doi: 10.1093/eurheartj/ehw028. Epub 2016 Feb 22.
Zotero 插件